Skip to main content

GOLDMAN SACHS GROUP INC

Position in BEAM — Beam Therapeutics Inc.

CIK 886982 NEW YORK, NY

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$44,961,223
+$20,994,368 QoQ
Shares Held
1,310,059
+30.3% QoQ
Ownership
1.27%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 274 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. BEAM ranks #71 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,961,223 1,310,059
2026-03-31 $23,966,855 1,005,743
2025-12-31 $14,487,469 522,636
2025-09-30 $32,003,707 1,318,653
2025-06-30 $21,825,922 1,283,123
2025-03-31 $13,224,973 677,162
2024-12-31 $17,852,627 719,864
2024-09-30 $16,680,775 680,848
2024-06-30 $18,382,310 784,563
2024-03-31 $18,245,083 552,212
2023-12-31 $13,178,562 484,150
2023-09-30 $11,104,292 461,717
2023-06-30 $23,181,977 726,025
2023-03-31 $20,155,859 658,258
2022-12-31 $39,829,310 1,018,392
2022-09-30 $50,101,843 1,051,676
2022-06-30 $36,926,513 953,927
2022-03-31 $47,515,852 829,247
2021-12-31 $77,619,493 974,018
2021-09-30 $90,845,574 1,044,082
2021-06-30 $83,409,742 648,044
2021-03-31 $58,766,728 734,217
2020-12-31 $68,674,995 841,193
2020-09-30 $7,663,935 311,289
2020-06-30 $8,807,036 314,537
2020-03-31 $6,533,244 362,958